[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"opioid-agonist-treatment\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:opioid-agonist-treatment":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":30,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":5},"100606702","mobile-platform-for-optimizing-wellness-and-engagement-in-recovery-100606702",false,"NCT07178990","Mobile Platform for Optimizing Wellness and Engagement in Recovery","MPOWER","Inclusion Criteria:\n\n* Participants must be enrolled in the Michigan Medicaid program\n* Opioid agonist treatment (OAT): Participants must have initiated OAT with buprenorphine or methadone\n* Participants must have an OAT prescription and Alcohol use disorder (AUD) based on self-report measure during screening\n* Participants must have regular access to a working smartphone and internet connection.\n* Participants must have a reliable mailing address to receive study supplies (e.g., salivary drug tests).\n\nExclusion Criteria:\n\n* Primary Medicare Coverage: Individuals that are dual-eligible for Medicaid and Medicare and aged 65 or older, due to limited availability of Medicaid claims data for this group\n* Individuals that cannot voluntarily provide informed consent themselves for any reason, including legal incompetency\n* Individuals with substantial cognitive impairment that would interfere with study participation\n* Individuals unable to read or understand English\n* Individuals experiencing active suicidality or psychosis.\n* Individuals with a planned admission to residential treatment or incarceration during the study period.","ALL","19 Years","63 Years",{"count":20,"type":21},50,"ESTIMATED","INTERVENTIONAL",[24],"NA","This pilot study addresses the urgent public health crisis of co-occurring opioid and alcohol use disorders (OUD-AUD), leading causes of mortality in the United States, by testing a scalable digital contingency management (CM) treatment among Medicaid beneficiaries. The study aims to evaluate the feasibility and acceptability of digital CM for OUD-AUD recovery, while also planning for broader implementation.",[27,28,29],"Opioid Agonist Treatment","Alcohol Use Disorder","Opioid Use Disorder",[31,32,33],"Research surveys","App based program","Smartphone","RECRUITING","2026-08-03",{"date":37,"type":38},"2026-08-06","ACTUAL",{"date":40,"type":38},"2025-12-08",{"date":42,"type":21},"2027-07-31",{"name":44,"class":45},"University of Michigan","OTHER"]